Glycosyl compounds
Apexbio Technology LLC EMODIN-8-GLUCOSIDE-5MG
Emodin-8-glucoside (CAS No 23313-21-5) is a naturally occurring anthraquinone glycoside with significant biomedical research interest particularly in oncology and anti-inflammatory studies It is derived from a variety of plant species often used in traditional medicine The compound modulates multiple signaling pathways including the inhibition of NF- B and modulation of reactive oxygen species (ROS) contributing to its therapeutic potential Emodin-8-glucoside exhibits in vitro activity typically in the nanomolar to low micromolar range making it a potent candidate for further research Its typical applications include cell-based assays and animal models for evaluating anti-cancer and anti-inflammatory effects Drug screening studies often utilize it to explore synergistic effects with other compounds Experimental concentrations typically depend on the specific research design allowing for tailored investigations into its diverse physiological actions
BIOHIPPO Research Grade Anti-Human APP/Amyloid beta Biosimilar Antibody (CNTO 2125), 100 µg
APP/Amyloid beta is a research-grade biosimilar antibody. It reacts with Human. Suitable for ELISA, FACS, Functional assay, Research in vivo. This research-grade biosimilar supports comparability, functional, PK/PD and immunogenicity studies. Supplied as 100 ug.